Pharmaceuticals & Therapeutics

For its 75th anniversary, the iconic rotisserie chain is partnering with pet retailer Mondou, tapping into the booming pet humanization market.

As Québec's population ages, a major healthcare union launches a campaign to confront systemic failures in senior care, challenging government strategy.

With a seasoned regulatory expert at the helm, Arletta Pharma is betting on its dual-action therapy, Lybrido, to transform the underserved FSIAD market.

A strategic pharma alliance scores a major win in Japan's lucrative neurology market, signaling a new competitive front and hope for thousands of patients.

Arverne CEO Pierre Brossollet's move to increase his stake is more than a vote of confidence; it's a strategic key unlocking a €70M investment.

Holcim's major acquisition of Xella signals a seismic shift in construction, betting big on sustainability. We explore the ripple effects of this deal.

A Las Vegas clinic offers a specialized program for first responders battling trauma and addiction. But does it address the systemic crisis facing our heroes?

Align Technology names Exact Sciences veteran Kevin Conroy its next Chairman, a strategic move signaling a new chapter of growth and innovation in digital dentistry.

A new AI tool scores meals on insulin impact, not calories. Can this data-driven approach disrupt the wellness market where others have stalled?

Brighton Marine's rebrand is more than a name change. It’s a calculated pivot to a self-sustaining social enterprise model where housing and healthcare are one.

With its Costco debut, FØRTE isn't just selling a protein bar; it's selling a solution to a market paradox. But can it disrupt the frozen aisle?

A small N.C. dispensary just outranked California's cannabis elite. Their secret? Redefining quality in a hazy market and proving craft can scale.

CosmoFarm hits a $60M run-rate with advanced robotics, but its record growth is set against the backdrop of parent Cosmos Health's 'going concern' warning.

AbbVie's latest dividend increase isn't just good news for investors; it's a window into the pharma giant's strategy for navigating future challenges.

Morningstar Farms' recall over plastic contamination is more than a consumer alert; it's a stress test for the entire plant-based food industry's rapid growth.

AdventHealth is pouring $214M into its Carrollwood hospital. It's not just a local expansion—it's a strategic move in a high-stakes race to serve Florida's boom.

Beyond the wrapper, Latvian confectioners are leveraging EU backing and sustainability claims to tap into Canada's conscious consumer market. But do the ethics match the indulgence?

The consumer safety watchdog is moving its HQ to downtown D.C. We dissect the claims of taxpayer savings, the strategic power play, and the human cost.

A local roofing expert's advice on costly repairs reveals a larger trend: how specialized knowledge and innovative media are reshaping community business strategy.

A scientific shift from replacement to regeneration is fueling a market set to surpass $100B. But can new players navigate the regulatory and commercial hurdles?